The authors documented that higher plasma glucagon levels at 30 min during the OGTT (Beta 0.145, SE 0.038, P = 1.2 × 10–4) were significantly associated with a T2D variant in EYA2, noting a 7.4% increase in plasma glucagon level per effect allele. This evidence concerns the gene GCG and type 2 diabetes mellitus.